Dermatitis, Eczematous Recruiting Phase 2 Trials for Benralizumab (DB12023)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03563066Effect of Benralizumab in Atopic DermatitisTreatment